An unsuspected imported disease: Meningo-encephalitis contracted in Spain;Een niet-vermoede importziekte: Meningo-encefalitis opgelopen in Spanje

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 3, 2004, Pages 113-117

  Thijssen, H S ^a   Leroy, P L J M ^b   Van't Hek, L G F M ^c   Hurkx, G A P T ^d  

^a Zuyderland Medical Centre   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ELKERLIEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CEFTRIAXONE; ERYTHROMYCIN; JOSAMYCIN;

ADOLESCENT; ARTICLE; BACTERIAL MENINGITIS; BORRELIA BURGDORFERI; BOUTONNEUSE FEVER; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; FEVER; HEADACHE; HERPES SIMPLEX ENCEPHALITIS; HUMAN; IMPORT DISEASE; MALE; MENINGOENCEPHALITIS; MULTIPLE ORGAN FAILURE; POLYMERASE CHAIN REACTION; RASH; RICKETTSIOSIS; SPAIN; TRAVEL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BOUTONNEUSE FEVER; COMMUNICATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MULTIPLE ORGAN FAILURE; PROGNOSIS; SPAIN; TRAVEL; TREATMENT OUTCOME;

EID: 0347764509     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Edwards MS, Feigin RD. Rickettsial diseases. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: Saunders; 1998. P. 2239-58.
2. Ruys ThA, Schrijver M, Ligthelm R, Wout JW van't. Fièvre boutonneuse opgelopen in Nederland: een reizende hond als bron van Rickettsia conorii. Ned Tijdschr Geneeskd 1994;138:2592-4.
3. Ezpeleta D, Muñoz-Blanco JL, Tabernero C, Gimenez-Roldan S. Neurological complications of Mediterranean boutonneuse fever. Neurologia 1999;14:38-42.
4. Font Creus B, Espejo Arenas E, Muñoz Espín T, Uriz Urzainqui S, Bella Cueto F, Segura Porta F. Fiebre botonosa mediterranea. Estudio de 246 casos. Medi Clin (Barc) 1991;96:121-5.
5. Raoult D, Weiller PJ, Chagnon A, Chauder H, Gallais H. Casanova P. Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases. Am J Trop Med Hyg 1986;35:845-50.
6. Bella F, Font B, Uriz S, Muñoz T, Espejo E, Traveria J, et al. Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever. Antimicrob Agents Chemother 1990;34:937-8.
7. Cascio A, Dones P, Romano A, Titone L. Clinical and laboratory findings of boutonneuse fever in Sicilian children. Eur J Pediatr 1998;157:482-6.
8. Raoult D, Zuchelli P, Weiller PJ, Charrel C, San Marco JL, Gallais H, et al. Incidence, clinical observations and risk factors in the severe form of Mediterranean spotted fever among patients admitted to hospital in Marseilles 1983-1984. J Infect 1986;12:111-6.
9. Yagupsky P. Mortality in serologically unconfirmed Mediterranean spotted fever. J Infect Dis 2000;181:809-12.
10. Yagupsky P, Wolach B. Fatal Israeli spotted fever in children. Clin Infect Dis 1993;17:850-3.
11. Abramson JS, Givner LB. Should tetracycline be contraindicated for therapy of presumed Rocky Mountain spotted fever in children less than 9 years of age? Pediatrics 1990;86:123-4.
12. Raoult D, Drancourt M. Antimicrobial therapy of rickettsial diseases. Antimicrob Agents Chemother 1991;35:2457-62.